Relapse of psoriasis after cyclin-dependent kinase 4 and 6 inhibitor: An emerging signalling pathway in cancer treatment and psoriasis

J Eur Acad Dermatol Venereol. 2023 Sep;37(9):e1134-e1135. doi: 10.1111/jdv.19148. Epub 2023 May 8.

Authors

Yi-An Chen^{1

2}, Ya-Tang Yang¹

Affiliations

¹ Department of Dermatology, Cathay General Hospital, Taipei, Taiwan.
² Department of Dermatology, Hsinchu Cathay General Hospital, Hsinchu, Taiwan.

PMID: 37114288
DOI: 10.1111/jdv.19148

No abstract available

Publication types

Letter

MeSH terms

Cyclin-Dependent Kinase 4 / metabolism
Humans
Neoplasms*
Psoriasis* / drug therapy
Psoriasis* / metabolism
Recurrence
Skin / metabolism

Substances

Cyclin-Dependent Kinase 4